2015/2018 - Clinical performance validation of a novel biomarker for quantitative imaging of coronary artery disease

zdjecie UE2

 

Clinical performance validation of a novel biomarker for quantitative imaging of coronary artery disease.

Synektik SA obecnie realizuje niniejszy projekt w ramach działalności CBR.

Beneficjent: Synektik SA
Wartość dofinansowania:3 687 250 EUR

 

Projekt finansowany w ramach: European Union’s Horizon 2020 Research and Innovation programme.

 

Synektik received funds for the project: “Clinical performance validation of a novel biomarker for quantitative imaging of coronary artery disease” under grant greement No 711083. 

 

Announcements